key: cord-0928712-93mrvgmb authors: Neppala, Sivaram; Sundarakumar, Dinesh Kumar; Caravella, Joseph W.; Chigurupati, Himaja Dutt; Patibandla, Prateek title: COVID-19-Associated Familial Acute Disseminated Encephalomyelitis (ADEM); A Case report date: 2021-09-01 journal: IDCases DOI: 10.1016/j.idcr.2021.e01264 sha: c18b84ea47a7d731cfbbc07b0cae3bd490c1699b doc_id: 928712 cord_uid: 93mrvgmb BACKGROUND: Several neurological complications are being reported in hospitalized patients with severe COVID-19 infection. This is presumed due to direct spread of infection or due to immunological response. Acute disseminated encephalomyelitis (ADEM) is a rare inflammatory and demyelinating disorder of the central nervous system that is often preceded by infection or vaccination. Very few cases of ADEM have been reported in the literature that are associated with COVID-19 infection. CASE REPORT: Here we demonstrate familial cases of ADEM in a hospitalized father and son, who presented to the emergency department with fever and shortness of breath, later diagnosed with COVID-19, and subsequently requiring mechanical ventilation. Both patients developed neurological symptoms with upper motor neuron involvement at approximately day 30 of admission. MRI of the brain demonstrated bilateral multifocal periventricular white matter FLAIR signal hyperintensities consistent with ADEM. The patients were treated with medium dose IV methylprednisolone with variable outcomes. The 49-year-old son developed severe residual neurological deficits with encephalomalacic changes on MRI which required extensive rehabilitation; meanwhile, the 68-year-old father predominantly had pulmonary sequelae including fibrosis and the development of a pneumatocele, but he had a better neurological outcome. CONCLUSION: To our knowledge, this is the first reported case report of ADEM involving father and son in severe COVID-19 infection. Final neurological outcomes in these patients appeared to be in line with the severity of COVID-19 infection. More research is needed to better understand the management of ADEM in patients with severe COVID-19 infection. including fibrosis and the development of a pneumatocele, but he had a better neurological outcome. To our knowledge, this is the first reported case report of ADEM involving father and son in severe COVID-19 infection. Final neurological outcomes in these patients appeared to be in line with the severity of COVID-19 infection. More research is needed to better understand the management of ADEM in patients with severe COVID-19 infection. Acute disseminated encephalomyelitis (ADEM) is a rare inflammatory demyelinating disorder that usually manifests one to three weeks following a viral infection or vaccination (11, 12) . ADEM is most common in children and young adults (16, 17) but very few cases have been reported in middle-aged and elderly patients (2, 18, 20) . ADEM is a monophasic illness with polymorphous clinical manifestations, that may pertain to motor, cerebellar, brainstem or myeloradicular involvement. In the absence of a specific biomarker, diagnosis may be made on MRI, which shows symmetrical multifocal white matter demyelinating lesions involving the brain and/or the spinal cord (4) . Being an immune-mediated disorder in nature, variable clinical outcomes in ADEM have been reported which were treated with either intravenous steroid or immunoglobulin therapy, however, no established treatment guidelines based on randomized clinical trials exist. Here we present two cases of patients with positive COVID-19 infection who developed neurological symptoms during the hospitalization. involves the brain and spinal cord is yet to be established; although, ACE-2 receptor-mediated injury to the neuronal and glial cells is widely considered as a putative mechanism of neurological injury causing demyelinating lesions in the brain and spinal cord (6, 8, 10) . Early detection of neurological deficits may improve treatment algorithms and potentially lead to better outcomes (5). Strokes have been commonly reported in COVID-19 patients (19) . While our patients had risk factors for stroke, neurovascular imaging and echocardiograms excluded large vessel territory strokes in our patients. Various inflammatory/demyelinating disorders were considered as differential diagnoses and were excluded in our patients before arriving at our final diagnoses. Multiple sclerosis (MS) was within the main differential diagnosis because of predominant white matter affliction and due to familial involvement (21) . However, the absence of oligoclonal Most neurological manifestations of ADEM typically occur around 2-4 weeks following viral illness or vaccination (11, 12) . In our patients, ADEM manifested late, around day 30 of hospitalization. The exact time of onset of neurological symptoms was difficult to ascertain as the patients were intubated and on paralytic agents. Radiologically, T2-weighted FLAIR sequences on MRI best depict the manifestations of ADEM (4, 7, 9) . In this case report, the initial MRI axial FLAIR sequence demonstrated prominent, bilateral periventricular white matter signal hyperintensities ( Figures A, B) based on which ADEM was suspected. On follow-up MRI in these patients, it was evident that the lesions in the father were stable, while some lesions in the son developed encephalomalacia ( Figures C, D respectively) , suggesting severe neuroglial tissue loss due to inflammation in the latter. Notably, the severity of the COVID-19 infection course in the son was worse compared to his father. Methylprednisolone is the initial treatment of choice for ADEM, although no controlled trials have established its superiority over other treatments. The outcome of ADEM using IV methylprednisolone is generally good, especially in children, with 57% to 81% of patients having complete recovery (16, 17) . Unfortunately, high dose steroids have been considered controversial in the treatment of COVID-19 at this time, with some studies even suggesting that high doses of steroids may be detrimental in COVID-19 disease course (13, 15 This case series of father and son with severe COVID-19 infection-related complications raises the possibility of a shared genetic susceptibility towards developing ADEM. The neurological outcome in these two hospitalized patients appeared to be dependent on the severity of the COVID-19 infection. As the COVID-19 pandemic unfolds, more information regarding the underlying risk factors, treatment, and prognosis will help us in treating these afflicted patients and their neurological complications. No written consent has been obtained from the patients as there is no patient identifiable data included in this case report. Data sharing not applicable to this article as no datasets were generated or analyzed during the current study. "The author(s) received no specific funding for this work." WHO Declares COVID-19 a Pandemic A Case of Acute Disseminated Encephalomyelitis in a Middle-Aged Adult Neurological manifestations of COVID-19 and other coronavirus infections: A systematic review The magnetic resonance imaging appearance of monophasic acute disseminated encephalomyelitis: an update post application of the 2007 consensus criteria Neuropathogenesis and Neurologic Manifestations of the Coronaviruses in the Age of Coronavirus Disease 2019: A Review Evidence of the COVID-19 Virus Targeting the CNS: Tissue Distribution, Host-Virus Interaction, and Proposed Neurotropic Mechanisms Acute Disseminated Encephalomyelitis. White Matter Diseases. 2020;109-125 Nervous system involvement after infection with COVID-19 and other coronaviruses Acute Disseminated Encephalomyelitis (ADEM) Expression of the SARS-CoV-2 cell receptor gene ACE2 in a wide variety of human tissues Post-vaccination encephalomyelitis: literature review and illustrative case Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease Corticosteroid treatment in severe COVID-19 pneumonia: two cases and literature review Acute Demyelinating Encephalomyelitis (ADEM) in COVID-19 infection: A Case Series The effect of corticosteroid treatment on patients with coronavirus infection: a systematic review and meta-analysis Clinical and neuroradiologic features of acute disseminated encephalomyelitis in children Acute disseminated encephalomyelitis, multiphasic disseminated encephalomyelitis and multiple sclerosis in children COVID-19-associated acute disseminated encephalomyelitis (ADEM) COVID-19 presenting as stroke Possible Acute Disseminated Encephalomyelitis Related to Severe Acute Respiratory Syndrome Coronavirus 2 Infection Differential Diagnosis Between Acute Disseminated Encephalomyelitis and Multiple Sclerosis During the First Episode COVID-19-associated Acute Hemorrhagic Necrotizing Encephalopathy: Imaging Features Dexamethasone in Hospitalized Patients with Covid-19